Substituted oxazolidinones for combinational therapy

US7767702B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Alexander Straub · Wuppertal, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Josef Pernerstorfer · Wuppertal, DE
• Elisabeth Perzborn · Wuppertal, DE
• Jens Pohlmann · Basel, CH
• Susanne Röhrig · Hilden, DE
• Karl-Heinz Schlemmer · Wuppertal, DE

Key dates

• Filing date: Jun 7, 2002
• Grant date: Aug 3, 2010
• Expiry date: Jun 12, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to combinations of A) oxazolidinones of formula (I) and B) other active ingredients, to a method for producing said combinations and to the use thereof as medicaments, in particular for the treatment and/or prophylaxis of thrombo-embolic diseases.